• Info
  • Insider Ownership

Insider Trading & Ownership of James Hassard

Location
Pasadena, CA
Summary
The estimated net worth of James Hassard is at least $5,241,615 dollars as of 09 Jul 2024. James Hassard is the Chief Commercial Officer of ARROWHEAD PHARMACEUTICALS, INC. and owns shares of ARROWHEAD PHARMACEUTICALS, INC. (ARWR) stock worth about $3.95M. James Hassard is the Chief Commercial Officer of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $1.29M.
Signature
Marc Wilson, as attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow James Hassard and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • James Hassard has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $5,241,615.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: ARROWHEAD PHARMACEUTICALS, INC. ($3,951,878).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of James Hassard

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ARWR ARROWHEAD PHARMACEUTICALS, INC. Chief Commercial Officer $3,951,878 22 Jun 2021
CRNX Crinetics Pharmaceuticals, Inc. Chief Commercial Officer $1,289,737 05 Jul 2024

Insider Transactions Reported by James Hassard:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored